Theratechnologies Inc (TH.TO) Quote|
United States

Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

4:00pm EDT
Change (% chg)

$-0.05 (-1.82%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for TH.TO


Theratechnologies Inc. is a Canada-based specialty pharmaceutical company. The Company addresses medical needs in metabolic disorders to promote healthy ageing among human immunodeficiency virus (HIV) patients. The Company's product, EGRIFTA (tesamorelin for injection), is used for the reduction of excess abdominal fat in... (more)


Beta: 1.98
Market Cap(Mil.): $181.32
Shares Outstanding(Mil.): 65.93
Dividend: --
Yield (%): --


  TH.TO Industry Sector
P/E (TTM): 74.12 33.67 34.69
EPS (TTM): 0.04 -- --
ROI: 8.19 14.91 14.13
ROE: 16.79 15.99 15.35

BRIEF-Theratechnologies and partner evaluating steps to seek and obtain approval of 1 mg/vial presentation

* Decided to withdraw marketing authorization application for registration of 2 mg/vial presentation of tesamorelin in Brazil

May 16 2016

BRIEF-Theratechnologies Q1 earnings per share C$0.00

* Theratechnologies announces financial results for first quarter of 2016

Mar 31 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : MacroRisk Analytics/EconomicInvestor
Provider : MacroRisk Analytics/EconomicInvestor
Provider : S&P Capital IQ Quantitative Report
Provider : Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.